Literature DB >> 22436866

Surgery, a prognostic marker for progression-free survival?

Marc C Chamberlain, Daniel L Silbergeld.   

Abstract

Mesh：

Year:  2012        PMID： 22436866      PMCID： PMC3309863          DOI： 10.1093/neuonc/nos057

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  2 in total

1.  Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Authors:  John K Park; Tiffany Hodges; Leopold Arko; Michael Shen; Donna Dello Iacono; Adrian McNabb; Nancy Olsen Bailey; Teri Nguyen Kreisl; Fabio M Iwamoto; Joohee Sul; Sungyoung Auh; Grace E Park; Howard A Fine; Peter McL Black
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Authors:  Jennifer L Clarke; Michele M Ennis; W K Alfred Yung; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Lisa M Deangelis; H Ian Robins; Frank S Lieberman; Howard A Fine; Lauren Abrey; Mark R Gilbert; Minesh Mehta; John G Kuhn; Kenneth D Aldape; Kathleen R Lamborn; Michael D Prados
Journal:  Neuro Oncol       Date:  2011-08-02       Impact factor: 12.300
  2 in total
  1 in total

1.  Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial.

Authors:  Orin Bloch; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2014-04-10       Impact factor: 12.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.